ChinaBio(R) LLC Release: Barclays Upgrades Outlook on Companies in China Healthcare Sector

Published: Aug 06, 2012

by Richard Daverman, PhD

August 3, 2012 -- Barclays Bank has raised its rating for companies in the China healthcare sector, moving to Positive. Six months ago, Barclays gave the sector a Negative rating. In fact, Jason Mann, MD, PhD, who is responsible for Barclays’ coverage of China‘s healthcare companies, titled his latest report “Clearer Skies Ahead." Dr. Mann based his improving outlook in part on a survey, conducted by ChinaBio®, showing that industry insiders have grown more optimistic about the future for their sector over the last six months. More details....

Back to news